SCHEMBL6003313

SCHEMBL6003313

C=C/C=[C]\c1cccc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CHAT P28329 1/20 0.38
ALDH1A1 P00352 7/20 0.37
HSD17B10 Q99714 5/20 0.37
CYP2A6 P11509 3/20 0.37
TSHR P16473 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
CYP1A2 P05177 5/20 0.35
HPGD P15428 3/20 0.35
CYP3A4 P08684 2/20 0.35
KEAP1 Q14145 1/20 0.35
GRM5 P41594 1/20 0.35
HPRT1 P00492 1/20 0.34
HTT P42858 2/20 0.34
ABCB11 O95342 1/20 0.33
NR3C1 P04150 1/20 0.33
ADRA2A P08913 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4916037 0.85 CA1 (0.36) CA1CA2CHATALDH1A1HSD17B10
SCHEMBL6003188 0.77 CHAT (0.39) CA1CA2CHATALDH1A1HSD17B10
SCHEMBL1611013 0.75 CHAT (0.43) CA1CA2CHATALDH1A1HSD17B10
SCHEMBL5598526 0.72 ALDH1A1 (0.43) ALDH1A1CYP2A6TSHRTDP1CYP1A2
SCHEMBL50728 0.72 CA1 (0.40) CA1CA2CHATALDH1A1HSD17B10
SCHEMBL59702 0.72 CA1 (0.69) CA1CA2CHATALDH1A1HSD17B10
SCHEMBL507946 0.72 CA1 (0.47) CA1CA2CHATALDH1A1HSD17B10
SCHEMBL8911901 0.72 CA1 (0.47) CA1CA2CHATALDH1A1HSD17B10
SCHEMBL5865111 0.72 CA1 (0.47) CA1CA2CHATALDH1A1HSD17B10
Formaldehyde SCHEMBL28349296 0.71 CA1 (0.68) CA1CA2CHATALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed